Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response-Reference-Cited by-同舟云学术

Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response

Published:2017-11-03 Issue:2 Volume:24 Page:351-359
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Muckenhuber Alexander,Berger Anne Katrin,Schlitter Anna Melissa,Steiger Katja,Konukiewitz Björn,Trumpp Andreas,Eils Roland,Werner Jens,Friess Helmut,Esposito Irene,Klöppel Günter,Ceyhan Güralp O.,Jesinghaus Moritz,Denkert Carsten,Bahra Marcus,Stenzinger Albrecht,Sprick Martin R.,Jäger Dirk,Springfeld Christoph,Weichert Wilko

Funder

DKTK

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic subtyping of gastrointestinal malignancies;Trends in Cancer;2024-09

2. Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal‐like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcome;The FASEB Journal;2024-08-05

3. A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction;Advanced Science;2024-06-17

4. KRT81 and HNF1A expression in pancreatic ductal adenocarcinoma: investigation of predictive and prognostic value of immunohistochemistry‐based subtyping;The Journal of Pathology: Clinical Research;2024-05

5. The prognostic, predictive and clinicopathological impact of KRT81 / HNF1A- and GATA6- based transcriptional subtyping in pancreatic cancer;2024-04-30